RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Panacos Pharmaceuticals P/E 2024

Panacos Pharmaceuticals P/E

-0.07

Panacos Pharmaceuticals Dividend yield

Ticker

PANC

ISIN

US69811Q1067

WKN

A0F50U

As of Jun 3, 2024, Panacos Pharmaceuticals's P/E ratio was -0.07, a -88.52% change from the -0.61 P/E ratio recorded in the previous year.

The Panacos Pharmaceuticals P/E history

Panacos Pharmaceuticals Aktienanalyse

What does Panacos Pharmaceuticals do?

Panacos Pharmaceuticals Inc. is a biotechnology company specializing in the research and development of innovative drugs against infectious diseases. The company was founded in 2000 by Demetrios T. Braddock and is headquartered in Watertown, Massachusetts, USA. Translated: Panacos Pharmaceuticals Inc. is a biotechnology company that specializes in the research and development of innovative drugs against infectious diseases. The company was founded in 2000 by Demetrios T. Braddock and is headquartered in Watertown, Massachusetts, USA. Panacos Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Panacos Pharmaceuticals's P/E Ratio

The Price to Earnings (P/E) Ratio of Panacos Pharmaceuticals is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Panacos Pharmaceuticals's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Panacos Pharmaceuticals is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Panacos Pharmaceuticals’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Panacos Pharmaceuticals Stock

What is the price-to-earnings ratio of Panacos Pharmaceuticals?

The price-earnings ratio of Panacos Pharmaceuticals is currently -0.07.

How has the price-earnings ratio of Panacos Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of Panacos Pharmaceuticals has increased by -88.52% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Panacos Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of Panacos Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of Panacos Pharmaceuticals affect the company?

An increase in the price-earnings ratio of Panacos Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Panacos Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of Panacos Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Panacos Pharmaceuticals?

Some factors that influence the price-earnings ratio of Panacos Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Panacos Pharmaceuticals pay?

Over the past 12 months, Panacos Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Panacos Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Panacos Pharmaceuticals?

The current dividend yield of Panacos Pharmaceuticals is .

When does Panacos Pharmaceuticals pay dividends?

Panacos Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Panacos Pharmaceuticals?

Panacos Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Panacos Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Panacos Pharmaceuticals located?

Panacos Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Panacos Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Panacos Pharmaceuticals from 6/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/3/2024.

When did Panacos Pharmaceuticals pay the last dividend?

The last dividend was paid out on 6/3/2024.

What was the dividend of Panacos Pharmaceuticals in the year 2023?

In the year 2023, Panacos Pharmaceuticals distributed 0 USD as dividends.

In which currency does Panacos Pharmaceuticals pay out the dividend?

The dividends of Panacos Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Panacos Pharmaceuticals

Our stock analysis for Panacos Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Panacos Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.